Atrial fibrillation is highly prevalent in patients with chronic kidney disease, reaching up to 32% in older patients on hemodialysis.
May prompt closer AF monitoring in advanced CKD; leaves open optimal management strategies pending prospective data.
Atrial fibrillation (AF) is the most common sustained arrhythmia in clinical practice, with a lifetime risk of 1 in 6 for subjects ! 40 years, even in the absence of structural heart disease. The prevalence of AF in patients with chronic kidney disease is notably high. The incidence of AF increases with decreases in the kidney function, and the prevalence of AF reaches 32% in older patients on hemodialysis.
No takes yet. Share an insight, caveat, or question.
Watanabe et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: